Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Role of Group Supportive Psychotherapy on Quality of Life and Its Relationship with Heart Rate Variability and Blood Serotonin Levels in End-Stage Renal Disease (ESRD) Patients Undergoing Chronic Hemodialysis.

Acta medica Indonesiana·2026
Same author

Comparability of venous versus capillary hemoglobin A1c measurements.

Diabetology international·2026
Same author

Performance of Tokyo Guidelines 2018 and Predictors of Mortality in Acute Cholangitis Patients in Indonesia.

Acta medica Indonesiana·2026
Same author

Temporal Changes in Inflammation, Oxidative Stress, Apoptosis, and Endothelial Glycocalyx Degradation in Correlation to Organ Function Assessment Following On-Pump Coronary Artery Bypass Graft Surgery.

Acta medica Indonesiana·2026
Same author

Development and usability testing of a depth camera-based web application for functionally relevant foot kinematics analysis.

Frontiers in medical technology·2025
Same author

Effects of traditional music therapy on the psycho-neuro-immuno-endocrine aspect of burnout syndrome in healthcare workers: A randomized controlled trial.

Narra J·2025

Related Experiment Video

Updated: Jun 16, 2026

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

The pre-diabetic epidemiological study in Depok, West Java.

Em Yunir1, Sarwono Waspadji, Ekowati Rahajeng

  • 1Department of Internal Medicine, University of Indonesia, Jakarta Pusat, Republic of Indonesia. dr_yunir@yahoo.com

Acta Medica Indonesiana
|February 4, 2010
PubMed
Summary
This summary is machine-generated.

This study found that 4.13% of adults in Depok have impaired fasting glucose (IFG) and 24.25% have impaired glucose tolerance (IGT). Overall, 33.96% of the population exhibits pre-diabetic conditions.

Related Experiment Videos

Last Updated: Jun 16, 2026

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

Area of Science:

  • Endocrinology
  • Public Health
  • Epidemiology

Background:

  • Pre-diabetes, characterized by impaired fasting glucose (IFG) and impaired glucose tolerance (IGT), is a growing public health concern.
  • Early identification and management of pre-diabetes are crucial for preventing progression to type 2 diabetes.

Purpose of the Study:

  • To determine the prevalence of IFG and IGT in the general adult population of Depok Area, West Java.
  • To assess the combined prevalence of IFG and IGT, indicating a pre-diabetic state.

Main Methods:

  • A two-stage random sampling method was employed in Depok Area, West Java, targeting individuals aged 25 years and above.
  • Data collection followed the WHO Step Wise Approach, defining pre-diabetes based on ADA 2003 criteria for IFG (fasting blood glucose 100-125 mg/dL) and IGT (2-hour glucose load 140-199 mg/dL).

Main Results:

  • Out of 969 eligible participants, 4.13% had isolated IFG, and 24.25% had isolated IGT.
  • A significant 5.68% of participants presented with mixed IFG and IGT.
  • The overall prevalence of pre-diabetes was found to be 33.96% in the study population.

Conclusions:

  • The study highlights a substantial prevalence of pre-diabetes in the Depok Area, with isolated IGT being more common than isolated IFG.
  • A considerable proportion of the population exhibits combined IFG and IGT, underscoring the need for targeted public health interventions.
  • These findings emphasize the importance of screening and early management strategies for pre-diabetes in this region.